A Study of Eltrekibart (LY3041658) in Healthy Participants
Clinical trial NCT07545590 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07545590
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-21
- Primary completion
- 2026-08-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.